Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Apr 7, 2019
Open Peer Review Period: Apr 8, 2019 - Apr 22, 2019
Date Accepted: Jul 3, 2019
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study

Abdulmughni J, Mahyoub EM, Alaghbari AT, Al Serouri AA, Khader Y

Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study

JMIR Public Health Surveill 2019;5(4):e14294

DOI: 10.2196/14294

PMID: 31584002

PMCID: 6797968

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study

  • Jihan Abdulmughni; 
  • Esam Mohammed Mahyoub; 
  • Abdulaziz Thabit Alaghbari; 
  • Abdulwahed Abdelgabar Al Serouri; 
  • Yousef Khader

Background:

Multidrug-resistant tuberculosis (MDR-TB) is a major challenge to ending TB occurrence by 2035. In Yemen, the 2011 survey showed an MDR-TB prevalence of 1.4% among new cases and 14.4% among previously treated cases. The National Tuberculosis Control Program (NTCP) established four MDR-TB sentinel surveillance sites in 2013 to monitor the MDR-TB situation. In Yemen, the 2011 survey showed an MDR-TB prevalence of 1.4% among new cases and 14.4% among previously treated cases. The NTCP established four MDR-TB sentinel surveillance sites in 2013 to monitor the MDR-TB situation.

Objective:

This study aimed to assess the performance of MDR-TB surveillance and determine its strengths and weaknesses.

Methods:

We used the updated Center for Diseases Control and Prevention guidelines for evaluating public health surveillance systems. Interviews were conducted with NTCP managers and Regional MDR-TB centers’ staff using a semistructured questionnaire. We used a 5-point Likert scale to assess the usefulness and other attributes (eg, simplicity and flexibility). The mean percentage was calculated for each attribute and used for the final rank of the performance: poor (<60%), average (60%-80%), and good (>80%).

Results:

The MDR-TB surveillance system achieved good performance in usefulness (87%), acceptability (82%), and data quality (91%); average performance in flexibility (61%) and simplicity (72%); and poor performance in stability (55%). The overall performance score was average (74%). Although strong commitment, good monitoring, and well-trained staff are the main strengths, depending on an external fund is a major weakness along with unavailability of the MDR-TB unit at the governorate level.

Conclusions:

Although the MDR-TB surveillance system has achieved an average overall performance, more efforts are required to improve its stability by ensuring constant power supply to enable laboratories to perform necessary diagnostic and follow-up tests. Gradual replacement of donors’ funds by the government is recommended. Scaling up of MDR-TB services and removing access barriers are crucial.


 Citation

Please cite as:

Abdulmughni J, Mahyoub EM, Alaghbari AT, Al Serouri AA, Khader Y

Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study

JMIR Public Health Surveill 2019;5(4):e14294

DOI: 10.2196/14294

PMID: 31584002

PMCID: 6797968

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.